Terms: = Ovarian cancer AND KIT, C-Kit, 3815, ENSG00000157404, CD117, SCFR, P10721 AND Staging
7 results:
1. Overexpression of Stathmin 1 Predicts Poor Prognosis and Promotes cancer Cell Proliferation and Migration in ovarian cancer.
Nie L; Zhang C; Song H; Zhao Q; Cheng L; Zhang P; Yang X
Dis Markers; 2022; 2022():3554100. PubMed ID: 35186166
[TBL] [Abstract] [Full Text] [Related]
2. RBBP6 aggravates the progression of ovarian cancer by targeting PIK3R6.
Liu YJ; Cui LL; Liu ZS; Jia RY; Ding YX; Xu LZ
Eur Rev Med Pharmacol Sci; 2020 Oct; 24(20):10366-10374. PubMed ID: 33155192
[TBL] [Abstract] [Full Text] [Related]
3. CircRNA_MYLK promotes malignant progression of ovarian cancer through regulating microRNA-652.
Zhao Y; Hu Y; Shen Q; Chen Q; Zhu XJ; Jiang SS; Zhang Q
Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5281-5291. PubMed ID: 32495861
[TBL] [Abstract] [Full Text] [Related]
4. Long non-coding RNA SNHG16 promotes cell growth and metastasis in ovarian cancer.
Yang XS; Wang GX; Luo L
Eur Rev Med Pharmacol Sci; 2018 Feb; 22(3):616-622. PubMed ID: 29461589
[TBL] [Abstract] [Full Text] [Related]
5. AIB1 regulates the ovarian cancer cell cycle through TUG1.
Li L; Gan ZH; Qin L; Jiao SH; Shi Y
Eur Rev Med Pharmacol Sci; 2017 Dec; 21(24):5610-5617. PubMed ID: 29271993
[TBL] [Abstract] [Full Text] [Related]
6. A clinicopathological review of 33 patients with vulvar melanoma identifies c-kit as a prognostic marker.
Heinzelmann-Schwarz VA; Nixdorf S; Valadan M; Diczbalis M; Olivier J; Otton G; Fedier A; Hacker NF; Scurry JP
Int J Mol Med; 2014 Apr; 33(4):784-94. PubMed ID: 24535703
[TBL] [Abstract] [Full Text] [Related]
7. ovarian nonsmall cell neuroendocrine carcinoma: a clinicopathologic and immunohistochemical study of 11 cases.
Veras E; Deavers MT; Silva EG; Malpica A
Am J Surg Pathol; 2007 May; 31(5):774-82. PubMed ID: 17460463
[TBL] [Abstract] [Full Text] [Related]
